Atlas Trials

Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

Clinical trial NCT00953537 · COMPLETED

Trial details

NCT number
NCT00953537
Sponsor
Centre Antoine Lacassagne
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2009-01-01
Primary completion
2011-01-01
Enrollment
303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.